
Kathryn Gallant joins Insight Health US as joint chief executive
pharmafile | January 14, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Gallant, insight health
The former managing partner for US health at Hall & Partners has joined the consultancy firm Insight Health US as joint chief executive.
Kathryn Gallant moves to the New York-based healthcare research consultancy from a key leadership role at Hall & Partners where she was responsible for managing a broad portfolio of global pharmaceutical clients, as well as a large full service research team across North America.
Gallant brings with her 14 years’ experience in market research spanning both global and US domestic healthcare research. She has a particular interest in the development of new, innovative research tools in the realms of qualitative, quantitative and anthropological research.
Preceding her eight-year tenure at Hall & Partners, Gallant was a director at Strategic Marketing Corporation (now GfK).
Jane Shirley, chief executive of parent company Insight Research Group, said: “We are delighted that Kathryn will be joining us to help drive the next stage of Insight’s growth in the US. Kathryn has a great reputation within the industry that fits perfectly with Insight’s focus on delivering top quality, truly insightful research.”
Gallant will be working alongside joint chief executive Jessica Cunningham. Avanti Ananthram who currently shares the role of chief executive at Insight Health US, will be taking up a new role later this year as head of International Development.






